Document is current
Any future updates will be listed below
-
Authors
Weber, Manuel http://orcid.org/0000-0002-9000-1319
Jentzen, Walter
Hofferber, Regina
Herrmann, Ken
Fendler, Wolfgang Peter
Conti, Maurizio
Wetter, Axel
Kersting, David
Rischpler, Christoph
Fragoso Costa, Pedro
-
Funding
Funding for this research was provided by:
Universitätsklinikum Essen
- License Information
-
More Information
Article History
Received: 20 May 2020
Accepted: 9 September 2020
First Online: 28 February 2021
Ethics approval and consent to participate
: The retrospective analysis of available patient data was performed in accordance with the declaration of Helsinki and approved by the local ethics committee (Ethics committee, University Duisburg-Essen, faculty of medicine, reference number: 20-9204-BO). Written informed consent was obtained by all participants.
: Not applicable.
: Manuel Weber, Regina Hofferber, Axel Wetter, David Kersting, Christoph Rischpler, and Pedro Fragoso Costa have nothing to disclose. W. Jentzen received research funding from Siemens Healthineers. Ken Herrmann reports personal fees from Bayer, personal fees and other from Sofie Biosciences, personal fees from SIRTEX, non-financial support from ABX, personal fees from Adacap, personal fees from Curium, personal fees from Endocyte, grants and personal fees from BTG, personal fees from IPSEN, personal fees from Siemens Healthineers, personal fees from GE Healthcare, personal fees from Amgen, personal fees from Novartis, personal fees from ymabs, outside the submitted work; Wolfgang P. Fendler is a consultant for Endocyte and BTG, and he received personal fees from RadioMedix outside of the submitted work. Maurizio Conti is an employee of Siemens Medical Solutions USA.
